Wegovy Without Insurance: Real Costs + Cheapest Legit Options (2026)

Wegovy without insurance costs $1,349.02 per month at list price—but most self-pay patients can pay $149–$349/month using Novo Nordisk's NovoCare savings offer, depending on whether you choose tablets (daily) or injections (weekly). Here's the fastest, cheapest legitimate path based on your situation.

What people actually pay in 2026:

Source: NovoCare Pharmacy pricing, verified January 2026

One hard truth: Even with the new $149–$349 self-pay pricing, Wegovy is still expensive—and if you're on Medicare or Medicaid, these manufacturer offers don't apply to you.

But here's the good news: Most people can still find a workable path. Tablets can lower the entry cost to $149/month, insurance appeals sometimes succeed when documentation is fixed, and your doctor can help you choose an FDA-approved alternative if Wegovy still isn't feasible.

Your fastest path forward:

1. If you want brand-name Wegovy: Sign up through NovoCare Pharmacy (Novo Nordisk's direct program) to access the $149–$349/month self-pay pricing.
2. If you need the lowest possible cost: Telehealth providers offer compounded semaglutide (marketed as containing semaglutide, but not FDA-approved) starting around $179/month with physician oversight included.
3. If your insurance denied you: Don't give up yet. We have an appeal playbook below that can help.

Now let's break down exactly how each option works, what the catches are, and how to avoid the scams.

---

Before we dive into the details, find yourself below. Your best path depends on where you're starting from.

"I don't have insurance at all." → Jump to: NovoCare Self-Pay Pricing or Compounded Semaglutide Options

"My insurance denied Wegovy." → Jump to: The Denial Reversal Playbook

"I have insurance but my copay is still too high." → Jump to: How to Stack Savings

"I need a prescription fast." → Jump to: Getting a Prescription Quickly

"I'm considering compounded semaglutide but I'm nervous." → Jump to: Compounded Semaglutide: Honest Risks and How to Reduce Them

---

Let's clear up the confusion about Wegovy pricing, because there are a lot of numbers floating around.

The Official List Price

Novo Nordisk sets Wegovy's list price at $1,349.02 for a 28-day supply. This applies to both the injection and the newer tablet form. Over a year, that's about $16,188 if you paid full price every month.

This is the number that shows up when:

• You don't have insurance
• Your insurance doesn't cover weight loss medications
• You go to a retail pharmacy without using any savings programs

But here's the thing: almost nobody should pay this price anymore.

Why Cash Prices Vary So Much

You might call three pharmacies and get three different quotes. That's because:

• Supply and demand: Some pharmacies have more stock than others
• Pharmacy contracts: Chains negotiate different wholesale prices
• Discount card acceptance: Not every pharmacy processes manufacturer offers the same way
• Geography: Prices can vary by region

This is why the "call the pharmacy" advice, while well-meaning, often creates more confusion than clarity.

The Real Numbers: What Self-Pay Patients Are Paying Right Now

In November 2025, Novo Nordisk made a significant move. They launched direct-to-consumer pricing through NovoCare Pharmacy that dramatically lowered the cost for people paying out of pocket.

Current NovoCare Self-Pay Pricing (verified January 2026):

Source: NovoCare Pharmacy terms, novocare.com. Government insurance beneficiaries (Medicare, Medicaid) are not eligible for these offers, even if they pay cash.

This is a genuine game-changer. A year ago, self-pay patients had almost no good options. Now, you can get brand-name, FDA-approved Wegovy for $149–$349/month depending on which form you choose.

Wegovy Injection vs. Wegovy Tablets: A Quick Clarification

Yes, there's now a Wegovy pill. The FDA approved it on December 22, 2025, and Novo Nordisk launched it in the U.S. in early January 2026.

Both forms contain the same active ingredient (semaglutide). The key differences:

The tablet's weight loss was 13.6% under the "treatment-policy" analysis (which counts everyone regardless of whether they stayed on treatment). Some reports cite ~16.6% under the "trial-product" analysis (which only counts people who adhered to treatment). Both numbers come from the same OASIS 4 trial.

Source: FDA-approved Wegovy prescribing information

There's no "generic Wegovy." Both the injection and tablet are brand-name products from Novo Nordisk. The tablet isn't a generic—it's just a different delivery method.

---

Let's rank your options from most to least recommended, based on cost, legitimacy, and practicality.

Option #1: NovoCare Self-Pay Savings (Best for Most People)

What it is: Novo Nordisk's official direct-to-consumer program that offers Wegovy at reduced prices for people paying out of pocket.

Who qualifies:

• No insurance, OR
• Insurance that doesn't cover Wegovy, OR
• Commercial insurance patients who choose to pay cash instead

Who doesn't qualify:

• Medicare beneficiaries
• Medicaid beneficiaries
• Other government insurance programs

How it works:

1. Get a prescription from any licensed provider (your doctor, telehealth, etc.)
2. Have the prescription sent to NovoCare Pharmacy
3. Text SAVE to 83757 to get the Wegovy Savings Offer details on your phone
4. If using NovoCare Pharmacy home delivery, your prescriber sends the prescription to NovoCare Pharmacy and you'll receive outreach to set up delivery

The pricing again (because it matters):

• Wegovy tablet 1.5 mg: $149/month
• Wegovy tablet 4 mg: $149/month (through April 15, 2026; then $199/month)
• Wegovy tablet 9 mg or 25 mg: $299/month
• Wegovy injection (0.25 mg or 0.5 mg, new patients only): $199/month for up to 2 fills through March 31, 2026
• Wegovy injection (all doses, standard price): $349/month

Pros:

• FDA-approved medication—you know exactly what you're getting
• Legitimate program run by the manufacturer
• No subscription fees or hidden costs
• Can use FSA/HSA funds

Cons:

• Still costs $149–$349/month (not cheap, but far better than $1,349)
• Government insurance beneficiaries can't use it
• You need a prescription first

Our take: If you can afford $149–$349/month and you want the peace of mind of FDA-approved medication, this is your best path. The tablet at $149/month is genuinely accessible for many people.

---

Option #2: Compounded Semaglutide Through Telehealth (Most Affordable)

What it is: Products marketed as containing semaglutide, prepared by licensed U.S. compounding pharmacies and prescribed through telehealth platforms. Compounded drugs are not FDA-approved and are not the same as Wegovy.

The honest truth upfront: Compounded semaglutide is not FDA-approved as a finished product. Regulatory oversight differs by pharmacy type—503A pharmacies are primarily state-licensed, while 503B outsourcing facilities register with the FDA. Quality and safety can vary.

This matters. The FDA has issued warnings about compounded GLP-1 medications, citing concerns about contamination, incorrect concentrations, and dosing errors from some providers.

Important regulatory update: The FDA declared the semaglutide injection shortage resolved in February 2025, and the enforcement discretion periods for compounding "essentially copies" of the drug ended in April–May 2025. If a provider offers compounded semaglutide now, ask what legal basis they're operating under. (We cover this in more detail in our compounded semaglutide risks section.)

That said: Some compounding may still occur under specific circumstances, and many people have used compounded semaglutide successfully with proper medical oversight. The key is choosing a reputable provider and understanding the tradeoffs.

What it typically costs:

Pros:

• Lower cost than brand-name
• Physician oversight included
• No insurance needed
• Often month-to-month (no long contracts)

Cons:

• Not FDA-approved as a finished product
• Quality varies by compounding pharmacy
• Regulatory landscape has changed (shortage no longer declared)
• FDA has expressed concerns about some compounded products

Who this makes sense for:

• People who can't afford $149–$349/month for brand-name
• People who understand and accept the tradeoffs
• People who choose a reputable provider with transparent pharmacy sourcing

We'll cover how to reduce risks with compounded semaglutide in detail below.

---

Option #3: Insurance Appeal (Worth Trying Even If You Think You'll Lose)

What it is: Fighting back when your insurance denies coverage for Wegovy.

Many people assume a denial is final. It's not. Appeals can work—especially when the initial denial was due to missing documentation or incorrect coding.

We have a full section on this below, but the short version:

• Many appealed denials do get overturned—the key is providing proper documentation
• The most common reasons for denial are fixable (missing weight history, wrong diagnosis code, step therapy requirements)
• Your employer's HR department can sometimes request coverage during benefits review

Cost if successful: As low as $0–$25/month with commercial insurance coverage

Effort required: Moderate (gathering documentation, writing appeal letter, following up)

Our take: If you have commercial insurance, it's worth at least one appeal attempt before assuming you need to pay out of pocket. We have templates below.

---

Option #4: Retail Pharmacy at Full Price (Almost Never Recommended)

What it is: Walking into CVS, Walgreens, Walmart, or Costco and paying the cash price without any savings program.

Cost: $1,349+ per month

When this might make sense:

• You need Wegovy today and can't wait for delivery
• You have significant FSA/HSA funds to use before they expire
• Money is genuinely not a concern

Our take: There's almost no reason to pay full retail when NovoCare offers the same medication for 75% less. Even if you're picking up at a retail pharmacy, use the NovoCare savings offer.

---

Let's address the "wegovy without insurance at [pharmacy]" question directly, because a lot of people search for this.

The honest answer: The list price is $1,349, but retail cash prices can vary by pharmacy and location. The biggest lever is whether you qualify for and use Novo Nordisk's savings/self-pay program—and whether you fill through NovoCare Pharmacy home delivery (the most reliable path to the discounted pricing).

What can change your price is how the prescription is processed, not where you fill it.

Here's what actually matters:

Option A: Fill at retail pharmacy WITH NovoCare savings

• Price: $149–$349/month (depending on formulation)
• How: Your provider sends the prescription to the pharmacy, and you have them run the NovoCare savings offer

Option B: Fill at retail pharmacy WITHOUT any savings

• Price: ~$1,349/month
• How: Walk in and pay cash (not recommended)

Option C: NovoCare home delivery

• Price: $149–$349/month
• How: Prescription goes directly to NovoCare Pharmacy, shipped to your door

Pharmacy-Specific Notes

CVS:

• Participates in NovoCare program
• Can fill Wegovy tablets and injections
• Ask them to "run the manufacturer savings offer"

Walgreens:

• Participates in NovoCare program
• Also has Walgreens Weight Management telehealth for getting prescriptions
• Same process—ask for manufacturer savings

Walmart:

• Cash price around $1,349
• Can process NovoCare savings
• Not part of the $4 generic program (Wegovy isn't generic)

Costco:

• Membership doesn't reduce Wegovy price
• Cash price similar to other pharmacies
• Costco partners with Sesame Care for telehealth prescriptions

The Call Script That Gets Real Numbers

If you want to price-check before committing, here's what to say:

"Hi, I'm checking the price for Wegovy [injection/tablet] at the [dose] strength. I'll be paying cash without insurance. Can you tell me:

1. The cash price without any discounts
2. The price if you run the NovoCare self-pay savings offer
3. If you have it in stock"

Have ready:

• The exact strength you need (injection: 0.25, 0.5, 1, 1.7, or 2.4 mg; tablet: 1.5, 4, 9, or 25 mg)
• That you want a 28-day supply (injection) or 30-day supply (tablet)

---

This section exists because "use the savings card" sounds simple but trips people up constantly. Here's exactly what needs to happen.

The Three Ways to Access NovoCare Pricing

Method 1: NovoCare Pharmacy Home Delivery

1. Your prescriber sends the prescription directly to NovoCare Pharmacy
2. You set up an account (text SAVE to 83757)
3. Medication ships to your home (free)
4. This is the most straightforward path

Method 2: Retail Pharmacy Pickup with Savings Offer

1. Your prescriber sends the prescription to a local pharmacy (CVS, Walgreens, etc.)
2. When you pick up, tell the pharmacist you want to use the NovoCare self-pay savings offer
3. They process it through their system
4. You pay the reduced price

Method 3: Digital Savings Card

1. Text SAVE to 83757 to receive the digital savings offer
2. Show it to the pharmacist when filling
3. They apply it at checkout

What to Say at the Pharmacy Counter

"I'd like to use the Wegovy self-pay savings offer through NovoCare. Can you run it as a cash-pay prescription with the manufacturer savings applied?"

If they seem confused, add:

"It should be through NovoCare. The BIN and information are on my digital savings card."

Troubleshooting: When Things Go Wrong

"The pharmacy says it's not covered"

• They might be running it through insurance first. Ask them to process it as cash-pay with the manufacturer offer, not through your insurance.

"The pharmacy can't find the savings card"

• Pull up the digital card on your phone (text SAVE to 83757 if you haven't)
• Give them the BIN, PCN, and Group numbers from the card

"Rejected for 'patient not eligible'"

• Check if you're on Medicare or Medicaid (government programs are excluded)
• Verify you haven't exceeded any usage limits

"My prescriber wrote the wrong form or strength"

• You'll need your prescriber to send a new prescription with the correct information

"I'm on Medicare/Medicaid"

• Unfortunately, the NovoCare self-pay savings offer excludes government insurance beneficiaries
• Your options are the full cash price or exploring compounded alternatives (see below)

---

Getting denied feels like a door slamming. But here's what most people don't realize: insurance denials are often just the first "no" in a negotiation.

Why Wegovy Gets Denied (The Usual Reasons)

Plan exclusion: Your insurance plan simply doesn't cover weight loss medications. This is more common than you might think—coverage for GLP-1 weight loss drugs is still limited. A 2025 employer survey found that only about 19% of large firms (200+ workers) reported covering GLP-1s for weight loss, meaning most employer plans don't.

Prior authorization required: Your insurer wants documentation before they'll approve coverage. This isn't a denial—it's a hurdle.

Step therapy: They want you to try cheaper options first (like Saxenda or lifestyle intervention) before approving Wegovy.

Documentation gaps: The most fixable reason. Your provider's notes didn't include enough information about your medical history, BMI, or previous weight loss attempts.

What Wegovy is FDA-Approved For (The Criteria Your Doctor Needs to Cite)

When you appeal, your documentation needs to show you meet FDA-approved criteria:

Adults:

• BMI ≥30 (obesity), OR
• BMI ≥27 (overweight) with at least one weight-related condition:
  • High blood pressure
  • Type 2 diabetes
  • High cholesterol/dyslipidemia

Adolescents (12+ years):

• Wegovy injection (not tablets) may be prescribed for chronic weight management in adolescents with obesity (BMI ≥95th percentile for age and sex). Wegovy tablets are not established for people under 18 years of age.

Additionally, Wegovy is FDA-approved to:

• Reduce risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with established heart disease who have obesity or overweight

Source: FDA-approved Wegovy prescribing information

The Prior Authorization Packet Checklist

If your provider is submitting (or resubmitting) for prior authorization, make sure these elements are included:

Required documentation:

• Current height and weight with calculated BMI
• Weight history over the past 2–5 years (showing chronic nature)
• List of weight-related comorbidities with supporting labs/records
• Previous weight loss attempts (diet, exercise, other medications)
• Current medications list
• Relevant lab work (A1C, lipid panel, etc. if applicable)

Diagnosis codes that support approval:

• E66.01: Morbid obesity due to excess calories
• E66.9: Obesity, unspecified
• Z68.35–Z68.45: BMI codes (adult, 35.0 and above)
• Plus any comorbidity codes (hypertension, T2D, etc.)

What strengthens your case:

• Documentation of failed lifestyle intervention
• Weight-related complications affecting quality of life
• Provider's letter of medical necessity

The Appeal Ladder

Step 1: Internal Appeal

After a denial, you have the right to an internal appeal. This is your chance to submit additional documentation and argue your case.

Timeline: Most plans require you to file within 180 days of denial.

What to include:

• Appeal letter (see template below)
• Updated clinical documentation
• Any new relevant information
• Peer-reviewed studies supporting GLP-1 use (if helpful)

Step 2: External Review

If the internal appeal fails, you can request an independent external review. A third party reviews your case.

Timeline: Must request within 4 months of internal appeal denial (for most plans).

Step 3: Employer/HR Route

If you have employer-sponsored insurance, you can also contact HR to:

• Ask if weight loss medications can be added during the next benefits review
• Request an exception based on medical necessity
• Inquire about wellness program coverage

Appeal Letter Template

Feel free to adapt this for your situation:

---

[Your Name] [Your Address] [Date]

[Insurance Company Name] [Claims/Appeals Address]

RE: Appeal of Wegovy Coverage Denial Member ID: [Your ID] Claim Number: [Claim #] Date of Denial: [Date]

Dear Appeals Committee,

I am writing to appeal the denial of coverage for Wegovy (semaglutide 2.4 mg), which was prescribed by my physician, [Provider Name], for the treatment of obesity.

Medical Necessity:

I meet the FDA-approved criteria for Wegovy:

• My current BMI is [X], which classifies as [obesity/overweight]
• I have the following weight-related medical conditions: [list conditions]
• I have attempted the following weight loss interventions without sustained success: [list previous attempts]

Clinical Support:

Wegovy has been shown in clinical trials to produce an average weight loss of 15–17% of body weight over 68 weeks when combined with lifestyle modification. For my weight of [X] pounds, this would represent approximately [X] pounds of weight loss, which would significantly improve my [specific health conditions].

Request:

I respectfully request that you reconsider this denial and approve coverage for Wegovy as medically necessary treatment for my condition.

Enclosed please find:

• Letter of medical necessity from my prescribing physician
• Relevant medical records documenting my weight history and comorbidities
• Lab results supporting my medical conditions

Thank you for your consideration of this appeal.

Sincerely,

[Your Signature] [Your Name]

---

Phone Script for Calling Your Insurance

"Hi, I'm calling about a coverage denial for Wegovy, claim number [X]. I'd like to understand exactly why it was denied and what documentation I would need to submit for an appeal. Can you also confirm the deadline for filing an appeal and where to send it?"

Write down:

• The specific denial reason (code if they give one)
• What additional documentation they suggest
• Appeal deadline
• Appeal mailing/fax address
• Name of representative you spoke with

---

Whether you're starting fresh or your current provider can't prescribe, here are your options for getting a legitimate prescription quickly.

Three Routes to a Wegovy Prescription

Route 1: Your Primary Care Doctor

Pros:

• They know your medical history
• Can coordinate with other medications
• May be covered by insurance for the visit

Cons:

• May require an appointment weeks out
• Some PCPs aren't comfortable prescribing GLP-1s
• May refer you to a specialist (more delay)

Route 2: Obesity Medicine or Endocrinology Specialist

Pros:

• Expert in weight management medications
• Can handle complex cases
• Good option if you have diabetes or other comorbidities

Cons:

• Often longer wait times for new patients
• May require referral from PCP

Route 3: Telehealth Weight Loss Providers

Pros:

• Fastest option (often same-day or next-day consultations)
• Designed specifically for GLP-1 prescriptions
• No referral needed

Cons:

• Out-of-pocket cost for the visit ($50–$150 typically)
• May not have access to your full medical records

What to Have Ready for Your Appointment

To avoid delays:

• Your current weight and height (for BMI calculation)
• Weight history (what you weighed 1, 2, 5 years ago if you know)
• List of all current medications and supplements
• List of medical conditions, especially weight-related ones
• Any previous weight loss attempts and results
• Family history of thyroid cancer (this is a contraindication for Wegovy)
• List of questions you want answered

Red Flags: How to Spot Illegitimate Providers

Not every online "weight loss clinic" is legitimate. Avoid any provider that:

• Sells medication without requiring a prescription
• Doesn't involve a licensed healthcare provider in the process
• Offers "research peptides" or "research semaglutide"
• Doesn't ask about your medical history
• Doesn't mention contraindications or side effects
• Prices seem too good to be true ($50/month for semaglutide is a red flag)
• No way to contact a real person with questions

The FDA has guidance on buying medications online safely: fda.gov/besaferx

---

Now that Wegovy comes in both injection and tablet form, you have a real choice. Here's how to decide.

Quick Comparison

The 13.6% figure is the treatment-policy analysis (all randomized patients). The trial-product analysis (full adherers) showed ~16.6%.

Source: FDA-approved Wegovy prescribing information

Choose the Injection If:

• You're comfortable with self-injection (or willing to learn—it's easier than you think)
• You prefer doing something once a week versus every day
• You have trouble remembering daily medications
• You've had gastric surgery that might affect pill absorption
• You want the formulation with the longest track record

Choose the Tablet If:

• You have a fear of needles or strong preference against injections
• You travel frequently (no refrigeration needed)
• You prefer a daily routine
• You want the slightly lower starting price ($149/month vs. $199)
• You're comfortable with the 30-minute wait before eating each morning

Can You Switch Between Them?

Yes. Your provider can help you transition from injection to tablet or vice versa. Since the active ingredient is the same (semaglutide), it's primarily a matter of adjusting doses and establishing the new routine.

Talk to your prescriber if you want to switch.

---

One of the most common questions is "when will I see results?" Here's a realistic timeline based on clinical trial data and real-world experience.

Month 1: The Adjustment Phase

What's happening: You're on the lowest dose (0.25 mg injection or 1.5 mg tablet), and your body is getting used to the medication.

What to expect:

• Appetite reduction may begin (often within the first week)
• Possible nausea, especially after meals
• Weight changes vary; focus on tolerating the medication during titration
• You might not feel dramatic effects yet—that's normal

What to do:

• Focus on tolerating the medication, not weight loss speed
• Eat smaller portions
• Stay hydrated
• Don't skip your dose trying to avoid side effects

Month 2: Building Momentum

What's happening: Dose increases to 0.5 mg injection or continues titrating on tablets.

What to expect:

• Side effects often peak then start improving
• Appetite suppression becomes more noticeable
• Food thoughts and cravings may decrease
• Weight changes vary by individual

What to do:

• Start establishing exercise habits if you haven't
• Focus on protein intake to preserve muscle
• Adjust meal timing around side effects

Months 3–4: The Acceleration

What's happening: You're reaching higher doses (1 mg, then 1.7 mg injection or higher tablet doses).

What to expect:

• Most side effects have improved significantly
• Many people notice more consistent changes
• Clothes may start fitting differently
• Energy often improves as weight drops
• Individual results vary widely

What to do:

• This is when results become visible to others
• Stay consistent with medication timing
• Don't plateau on purpose—continue dose escalation per your provider's guidance

Months 5–6: Reaching Therapeutic Dose

What's happening: You're at or approaching the maintenance dose (2.4 mg injection or 25 mg tablet).

What to expect:

• Maximum appetite suppression at therapeutic dose
• Steady continued progress for most people
• Some people reach goal weight, others are making strong progress
• Individual results vary; clinical trial averages were ~15% body weight by month 16

What to do:

• Work with your provider on whether to continue escalating
• Focus on lifestyle changes that will support maintenance
• Consider adding strength training if you haven't

Months 6–12: Approaching Maximum Effect

What's happening: You're at full therapeutic dose and seeing the full effect of the medication.

What to expect:

• Weight loss rate may slow (this is normal—you're getting closer to your body's new equilibrium)
• Clinical trials show 15–17% body weight loss by this point
• Health markers (blood pressure, blood sugar, cholesterol) often improve significantly
• Many people reach or approach their goal weight

What to do:

• Keep taking the medication—stopping typically leads to regain
• Celebrate non-scale victories (how you feel, how clothes fit, lab improvements)
• Work with your provider on a long-term maintenance plan

Year 2 and Beyond: Maintenance

What's happening: You're maintaining the weight loss you've achieved.

What to expect:

• Most people need to continue medication to maintain results
• In the STEP 1 trial extension, participants regained about two-thirds of their prior weight loss one year after stopping semaglutide 2.4 mg; real-world outcomes vary
• Some people try reducing dose with provider guidance
• Continued health benefits as long as weight is maintained

What to do:

• Budget for ongoing medication costs
• Don't view this as a temporary treatment
• Continue lifestyle habits that support your health

Real-World Expectations vs. Clinical Trial Averages

Clinical trials report averages, but individual results vary widely. Here's what you should know:

• Average weight loss: ~15% of body weight over 68 weeks (injection) or ~13.6% over 64 weeks (tablet in standard analysis)
• Clinical trial results vary: In the STEP 1 trial, participants lost an average of ~15% body weight on semaglutide 2.4 mg; individual results differ
• Why results vary: Genetics, adherence, starting weight, diet, activity level, and other factors all play a role

If you're not seeing expected results, talk to your provider before giving up. Sometimes dose adjustments or adding other strategies can help.

---

This section is required reading before you start. Wegovy is effective, but it's not without side effects—and there are some situations where you shouldn't take it at all.

The Boxed Warning (Read This)

Wegovy carries an FDA boxed warning about thyroid C-cell tumors:

"In rodents, semaglutide caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether Wegovy causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans."

Source: FDA-approved Wegovy prescribing information

What this means for you:

• Do NOT take Wegovy if you or a family member has had medullary thyroid carcinoma (MTC)
• Do NOT take Wegovy if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• If you develop a lump in your neck, hoarseness, trouble swallowing, or shortness of breath, stop taking Wegovy and tell your doctor immediately

Rodent studies showed thyroid C-cell tumors; the human relevance of this finding has not been determined, which is why the boxed warning remains.

For a complete breakdown, see our GLP-1 contraindications guide.

Who Should NOT Take Wegovy

Beyond the thyroid warning, Wegovy is contraindicated for people with:

• Personal or family history of MTC or MEN 2
• Known serious hypersensitivity to semaglutide or any ingredients
• Pregnancy: Do not use Wegovy during pregnancy; stop at least 2 months before a planned pregnancy

Use with caution if you have:

• History of pancreatitis
• Diabetic retinopathy
• Kidney problems
• History of depression or suicidal thoughts
• Gallbladder problems

Always disclose your full medical history to your prescriber.

Common Side Effects (What Most People Experience)

The most frequent side effects are gastrointestinal and typically improve over time:

Source: FDA-approved Wegovy prescribing information

Why they happen: Semaglutide slows gastric emptying (how fast food leaves your stomach) and affects appetite signals in your brain. Your body needs time to adjust.

Why the slow dose escalation matters: You start at the lowest dose (0.25 mg injection or 1.5 mg tablet) and gradually increase over 16–20 weeks. This isn't to make you wait—it's to minimize side effects by letting your body adapt.

For tips on managing specific side effects, see our GLP-1 side effects relief tool.

Serious Side Effects (Less Common, But Know the Signs)

Pancreatitis:

• Signs: Severe pain in your stomach area (abdomen) that doesn't go away, with or without vomiting
• Action: Stop taking Wegovy and call your doctor immediately

Gallbladder problems:

• Signs: Pain in upper stomach, fever, yellowing of skin/eyes, clay-colored stools
• Action: Call your doctor

Kidney problems:

• Signs: Changes in urination, swelling in legs/feet
• Action: Especially important if you have diarrhea, nausea, or vomiting—dehydration can worsen kidney function

Hypoglycemia (low blood sugar):

• Primarily a concern if you take Wegovy with insulin or sulfonylureas
• Signs: Dizziness, sweating, confusion, shakiness
• Action: Check blood sugar, treat with glucose, and talk to your doctor about adjusting other diabetes medications

Allergic reactions:

• Signs: Swelling of face, lips, tongue, or throat; difficulty breathing or swallowing; severe rash
• Action: Stop Wegovy and seek emergency medical care

Tips to Minimize Side Effects

1. Follow the dose escalation schedule. Don't try to speed it up.
2. Eat smaller meals. Your stomach empties slower now—large meals will make you feel worse.
3. Avoid fatty, greasy, or fried foods. These are harder to digest and worsen nausea.
4. Stay hydrated. Drink at least 64 oz of water daily. More if you have diarrhea or vomiting.
5. Eat protein first. This helps maintain muscle mass while losing fat.
6. Avoid lying down right after eating. Wait at least 30 minutes.
7. Ask about anti-nausea medication. Your provider can prescribe something if nausea is severe.

---

Even with NovoCare pricing, $149–$349/month may not fit everyone's budget. Here are legitimate alternatives to consider.

Other FDA-Approved GLP-1 Options

Zepbound (tirzepatide):

• Eli Lilly's GLP-1/GIP dual agonist
• May produce slightly more weight loss than semaglutide for some people
• Self-pay price: $299–$449/month through Eli Lilly's direct program (LillyDirect vials)
• Worth considering if Wegovy isn't available or you want to try a different mechanism

Ozempic (semaglutide):

• Same active ingredient as Wegovy, FDA-approved for type 2 diabetes
• Sometimes prescribed off-label for weight loss
• Self-pay price through NovoCare: $349–$499/month
• Note: If your primary goal is weight loss and you don't have diabetes, Wegovy is the appropriate prescription

Saxenda (liraglutide):

• An older GLP-1 approved for weight loss
• Daily injection (not weekly)
• Generally less effective than semaglutide (about 5–8% weight loss vs. 15%+)
• Price: ~$1,000/month without savings programs

Non-GLP-1 Prescription Options

Contrave (bupropion/naltrexone):

• Oral medication, twice daily
• Average weight loss: 5–10%
• Cost: ~$99/month with manufacturer coupon
• May be a good option for people who can't take GLP-1s

Qsymia (phentermine/topiramate):

• Oral medication
• Average weight loss: 7–10%
• Dispensed only through certified pharmacies under the Qsymia REMS
• Cost varies by pharmacy; Qsymia promotes a ~$98 cash price option through its savings program (after benefits verification)

Plenity:

• FDA-cleared prescription hydrogel capsules
• Takes up space in stomach, promotes fullness
• In one 6-month trial, Plenity users lost about 6.4% on average vs 4.4% with placebo; results vary
• Cost: ~$98/month

The Decision Framework

Ask yourself:

1. What's my monthly budget? This narrows options quickly.
2. Am I comfortable with injections? If not, oral options exist.
3. Do I have any contraindications? Some meds are ruled out by your medical history.
4. What did my provider recommend? They know your full picture.

Our general guidance:

• Budget $150–$350/month → Brand-name Wegovy through NovoCare
• Budget $100–$200/month → Compounded semaglutide (with caveats, see below)
• Budget under $100/month → Non-GLP-1 options like Contrave

---

We've mentioned compounded semaglutide several times. Now let's address it fully, because this is where people make mistakes.

What "Compounded" Actually Means

Compounded medications are custom-prepared by licensed pharmacies based on individual prescriptions. This is legal and has a long history in medicine—especially when commercial products are unavailable or when patients need custom doses or formulations.

Wegovy's active ingredient is semaglutide. Some compounded products are marketed as semaglutide, but compounded drugs are not FDA-approved, may vary by pharmacy, and are not the same as Wegovy. The difference is in how it's prepared:

Brand-name Wegovy:

• Manufactured by Novo Nordisk
• FDA-approved (meaning the specific formulation has undergone rigorous clinical trials)
• Consistent production in large batches
• Specific excipients (inactive ingredients)

Compounded semaglutide:

• Prepared by compounding pharmacies using pharmaceutical-grade semaglutide
• NOT FDA-approved as a finished product (the raw ingredient is pharmaceutical grade, but the final formulation isn't reviewed by FDA)
• Made in smaller batches, sometimes to order
• May use different excipients

The FDA's Concerns (Worth Reading)

The FDA has issued multiple communications about compounded GLP-1 medications:

"FDA is concerned about the safety risks to patients who use compounded drugs and the potential for harm from sterility or potency issues that may arise from drugs compounded by outsourcing facilities that are not operating in compliance with FDA requirements."

Additionally, the FDA has warned specifically about:

• Dosing errors: Some compounded products use different concentration expressions (units vs. mg), leading to confusion and potentially dangerous over- or under-dosing
• Contamination: Not all compounding pharmacies maintain proper sterile conditions
• Semaglutide salts: Some products use "semaglutide sodium" or "semaglutide acetate," which are different from the semaglutide base used in Wegovy—and may behave differently in the body

Source: FDA Alerts on Compounded Semaglutide

Important 2026 Update on Compounded Semaglutide

Here's the legal reality: The FDA announced the semaglutide injection shortage was resolved on February 21, 2025. Following that determination, the FDA set time-limited enforcement discretion periods:

• 503A compounding pharmacies (state-licensed): Enforcement discretion ended April 22, 2025
• 503B outsourcing facilities: Enforcement discretion ended May 22, 2025

In plain English: Routine mass compounding of "copycat" semaglutide injections—products that are essentially copies of FDA-approved Wegovy—is generally no longer allowed under the shortage exception.

Source: FDA Declaratory Order on Semaglutide Shortage Resolution, February 21, 2025

What this means for patients in 2026:

If a telehealth company still offers "compounded semaglutide," ask them:

1. Which pharmacy fills the prescriptions?
2. What legal basis are they relying on?
3. Is this a patient-specific compounded product, or a copy of the commercial product?

Some compounding may still occur under specific circumstances (such as patient-specific modifications that are clinically necessary), but the broad "shortage exception" no longer applies to semaglutide injections.

Regulatory oversight differs by pharmacy type: 503A compounding pharmacies are primarily state-licensed, while 503B outsourcing facilities register with the FDA. Oversight and quality systems can vary—so you should verify the pharmacy details before proceeding.

How to Reduce Risk If You Choose Compounded

If cost makes compounded semaglutide your only realistic option, here's how to be safer about it:

1. Require physician oversight Never use any compounded GLP-1 without a licensed prescriber involved. This isn't just about getting a prescription—they should monitor your progress and adjust dosing.

2. Ask about the compounding pharmacy Reputable telehealth providers will tell you which pharmacy fills their prescriptions. Look for:

• State pharmacy license
• FDA facility registration (as an outsourcing facility or 503A pharmacy)
• Accreditation (PCAB accreditation is a plus)
• USP 797/800 compliance (standards for sterile compounding)

3. Verify what you're getting The medication should clearly state:

• "Semaglutide" (not semaglutide sodium, semaglutide acetate, or other variants)
• Concentration in mg (not vague "units")
• Proper storage instructions
• Expiration date
• Pharmacy name and license information

4. Watch for red flags Avoid any provider where:

• Pricing seems impossibly low (under $100/month for semaglutide is suspicious)
• No licensed prescriber is involved
• They can't or won't name the compounding pharmacy
• The medication arrives without proper labeling
• No instructions on dosing, storage, or administration

5. Use the FDA's BeSafeRx tool The FDA maintains a resource to verify online pharmacies: fda.gov/besaferx

Our Take on Compounded Semaglutide

We're not going to tell you to never use compounded semaglutide—that's not realistic given the cost barriers many people face.

But we will say: go in with eyes open. You're accepting some additional risk compared to FDA-approved medication. Minimize that risk by choosing reputable providers and staying under medical supervision.

---

If you're going the telehealth route—whether for brand-name Wegovy or compounded semaglutide—here's how several providers compare.

How We Evaluated Providers

We looked at:

• What medications they offer (brand-name, compounded, or both)
• Pricing (starting and ongoing)
• What's included (consultation, medication, support, labs)
• Cancellation and refund policies
• State availability

We note where information is "provider-stated" (from their website) vs. "verified" (independently confirmed).

Provider Comparison Table

Notes: Prices verified January 2026 where possible. Provider-stated prices may change. Government insurance beneficiaries (Medicare/Medicaid) have limited options.

For a detailed breakdown of all telehealth weight loss providers, see our best GLP-1 online programs comparison.

Important Notes on Telehealth

Not all telehealth is equal. Some providers are essentially prescription mills; others offer genuine medical oversight. At minimum, any legitimate telehealth weight loss provider should:

• Require a health questionnaire
• Have a licensed clinician review your case
• Ask about contraindications
• Offer ongoing support or follow-ups
• Be transparent about what medication you're getting and where it comes from

---

The demand for GLP-1 medications has created a market for scammers. Protect yourself.

Red Flags That Scream "Scam"

• "No prescription needed": Semaglutide is a prescription medication. Anyone selling it without one is operating illegally.
• "Research peptides" or "for research purposes only": This is a legal workaround to sell unregulated substances. Do not inject research peptides into your body.
• Prices that seem impossible: If brand-name Wegovy is $149 minimum from the manufacturer, and someone's offering it for $50, it's not real Wegovy.
• No clinician involvement: Legitimate providers have licensed healthcare professionals involved in prescribing.
• Cryptocurrency or wire transfer only: Legitimate pharmacies take credit cards and have normal payment processing.
• Shipping from overseas: Most counterfeit GLP-1s enter the US through international shipments.

What Counterfeit Semaglutide Actually Looks Like

The FDA has seized counterfeit Ozempic and Wegovy products. Some contained:

• No semaglutide at all
• Different drugs entirely
• Wrong concentrations
• Bacterial contamination

These aren't theoretical risks—they've happened.

Source: FDA Safety Communication on Counterfeit Ozempic

How to Protect Yourself

1. Only buy from licensed U.S. pharmacies or verified manufacturer programs
2. Check the FDA's BeSafeRx database before using any online pharmacy: fda.gov/besaferx
3. Verify the medication when it arrives: Look for proper labeling, lot numbers, expiration dates, and intact packaging
4. If something seems off, don't use it: Contact your pharmacy or provider immediately
5. Report suspected counterfeits: FDA's MedWatch program takes reports at fda.gov/medwatch

---

Before you go any further, let's make sure you're likely to qualify for Wegovy (or any semaglutide treatment).

Basic Requirements

You're likely eligible if:

Adults:

• BMI ≥30 (obesity), OR
• BMI ≥27 (overweight) with at least one weight-related condition

Adolescents (12+ years):

• Wegovy injection (not tablets) may be prescribed for adolescents with obesity (BMI ≥95th percentile for age and sex). Wegovy tablets are not established for people under 18 years of age.

Quick BMI Reference

Weight-Related Conditions That Qualify You

If your BMI is 27–29.9, you need at least one of these:

• High blood pressure (hypertension)
• Type 2 diabetes
• High cholesterol (dyslipidemia)
• Sleep apnea
• Cardiovascular disease
• PCOS (polycystic ovary syndrome)
• Fatty liver disease

Who Should NOT Take Wegovy

Absolute contraindications:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Known allergy to semaglutide or any ingredients
• Pregnancy/Breastfeeding: Do not use Wegovy during pregnancy (stop at least 2 months before a planned pregnancy). Breastfeeding is not recommended during Wegovy tablets; for injection, it is not known if semaglutide passes into breast milk—discuss with your clinician

Use with caution (discuss with provider):

• History of pancreatitis
• Diabetic retinopathy
• Severe kidney disease
• History of gallbladder problems
• History of depression or suicidal thoughts

For the complete breakdown, see our GLP-1 contraindications guide.

What to Expect at Your Evaluation

A prescriber will typically:

1. Calculate your BMI based on current height and weight
2. Review your medical history
3. Ask about previous weight loss attempts
4. Check for contraindications
5. Discuss expectations, side effects, and commitment
6. If appropriate, write the prescription

Most telehealth evaluations take 15–30 minutes. Eligibility depends on your BMI, comorbidities, contraindications, and the clinician's judgment—but if you meet the BMI criteria and don't have contraindications, most people do qualify.

Take our GLP-1 eligibility quiz to see if you're a candidate.

---

How much is Wegovy without insurance?

The list price is $1,349 per month. However, through NovoCare Pharmacy's self-pay program, you can get Wegovy tablets for $149–$299/month or Wegovy injections for $199–$349/month. Compounded semaglutide through telehealth providers typically costs $149–$299/month.

What's the cheapest way to get Wegovy without insurance?

The cheapest option for brand-name Wegovy is the tablet form through NovoCare at $149/month (for the 1.5 mg and 4 mg doses). If you're open to compounded semaglutide (not FDA-approved), prices start around $149–$179/month through telehealth providers.

Does the Wegovy savings card work without insurance?

Yes. Novo Nordisk's savings program has a self-pay option specifically for people without insurance or whose insurance doesn't cover Wegovy. Through this program, you can access the $149–$349/month pricing.

How much is Wegovy at CVS without insurance?

Without any savings, CVS cash prices can be near the $1,349 list price (varies by location and discount programs). To access Novo Nordisk's official self-pay pricing (tablets $149–$299; injection $199 intro/$349 ongoing for eligible patients), the most reliable path is NovoCare Pharmacy home delivery. If you prefer CVS pickup, ask whether they can process the Wegovy savings offer and what your final out-of-pocket would be—results vary.

How much is Wegovy at Costco without insurance?

Costco cash prices can be near the $1,349 list price (varies by location). Membership doesn't automatically make Wegovy "cheap." For the manufacturer's official self-pay pricing, use NovoCare Pharmacy home delivery; if you prefer Costco pickup, call and ask whether they can process the Wegovy savings offer and what your final out-of-pocket would be.

Is there a generic Wegovy?

No. There is no generic version of Wegovy. Novo Nordisk holds the patent on semaglutide. The Wegovy tablet is not a generic—it's a different formulation of the same brand-name drug.

What's the difference between Wegovy and compounded semaglutide?

Wegovy is FDA-approved, manufactured by Novo Nordisk with consistent quality control, and has extensive clinical trial data. Some compounded products are marketed as containing semaglutide, but compounded drugs are not FDA-approved, are not the same as Wegovy, and may vary in formulation and quality depending on the pharmacy.

Is compounded semaglutide safe?

Compounded semaglutide can be used safely with proper medical oversight and when sourced from reputable, licensed compounding pharmacies. However, the FDA has issued warnings about risks including contamination, incorrect concentrations, and dosing errors from some compounders. If you choose compounded semaglutide, verify the pharmacy's credentials and ensure you have physician supervision.

Can I get Wegovy if my insurance denied it?

Possibly. Insurance denials can be appealed, and many are overturned when additional documentation is provided. Common fixable issues include missing weight history, incorrect diagnosis codes, or not meeting step therapy requirements. If your appeal fails, you can still access Wegovy through NovoCare's self-pay program.

What if I have Medicare or Medicaid?

Unfortunately, Medicare and Medicaid beneficiaries are excluded from Novo Nordisk's self-pay savings programs. Your options are the full retail price (not recommended) or exploring whether Wegovy might be covered under a different indication (such as cardiovascular risk reduction if you have established heart disease). Compounded semaglutide may also be an option, but verify the provider accepts your situation.

How long does it take to get Wegovy without insurance?

With telehealth providers, you can typically complete a consultation and receive a prescription within 24–48 hours. If using NovoCare Pharmacy home delivery, medication usually ships within a few days. Retail pharmacy pickup with NovoCare savings can be same-day if the pharmacy has stock.

Is the Wegovy pill as effective as the injection?

Clinical trials showed the injection produced about 15% body weight loss over 68 weeks, while the tablet produced about 13.6% over 64 weeks (treatment-policy analysis). Both are considered highly effective. The small difference may be due to study design rather than medication efficacy. Your provider can help you choose based on your preferences and lifestyle.

---

FDA Sources

• FDA-approved Wegovy Prescribing Information
• FDA Alerts on Compounded Semaglutide
• FDA Safety Communication on Counterfeit Ozempic
• FDA BeSafeRx: Know Your Online Pharmacy

Manufacturer Sources

• NovoCare Pharmacy Savings Programs
• Wegovy Official Website

Related Guides on This Site

• GLP-1 Contraindications Guide - Who should NOT take GLP-1 medications
• GLP-1 Side Effects Relief Tool - Managing common side effects
• Best GLP-1 Online Programs - Complete provider comparison
• GLP-1 Eligibility Quiz - See if you qualify

---

Primary sources first: We reviewed the FDA-approved Wegovy prescribing information, NovoCare Pharmacy pricing terms, and FDA safety communications on compounded semaglutide.

Pricing verification: NovoCare self-pay pricing was verified in January 2026. Telehealth provider pricing is noted as "provider-stated" where not independently verified.

Clear distinction: We distinguish between FDA-approved brand-name medications and compounded alternatives, with honest disclosure of the tradeoffs for each option.

No miracle claims: Weight loss percentages come from published clinical trial data. Individual results vary.

---

We verify pricing information monthly and update this page when manufacturer programs or telehealth pricing changes.

We may earn a commission if you purchase through our affiliate links, at no extra cost to you. All providers conduct medical evaluations—you'll only receive treatment if approved by a licensed prescriber. See our advertising disclosure for details.